In models of NAFLD-associated HCC, LCAT deficiency exacerbates lipid droplet formation and promotes a tumorigenic microenvironment through oxysterol-mediated LXRα activation [39, 40]. Here, NR1H3 is linked to metabolic dysfunction-associated steatotic liver disease.